These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 19248599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Using doxasosine and finasteride combination in the treatment of prostate adenoma].
    Bogdanov AB, Luk'ianov IV, Veliev EI.
    Urologiia; 2006; (5):59-63. PubMed ID: 17444154
    [Abstract] [Full Text] [Related]

  • 3. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
    McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.
    N Engl J Med; 2003 Dec 18; 349(25):2387-98. PubMed ID: 14681504
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of combined treatment of large prostatic adenoma with doxasozine and finasteride].
    Tarasov NI, Izmaĭlov RI.
    Urologiia; 2009 Dec 18; (5):40-5. PubMed ID: 20209869
    [Abstract] [Full Text] [Related]

  • 5. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW.
    J Urol; 2014 Jun 18; 191(6):1828-34. PubMed ID: 24342143
    [Abstract] [Full Text] [Related]

  • 6. The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Fitzpatrick JM, Desgrandchamps F.
    BJU Int; 2005 Mar 18; 95(4):575-9. PubMed ID: 15705083
    [Abstract] [Full Text] [Related]

  • 7. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB, Pushkar' DIu, Rasner PI.
    Urologiia; 2002 Mar 18; (1):19-22. PubMed ID: 11877966
    [Abstract] [Full Text] [Related]

  • 8. Two-drug therapy is best for symptomatic prostate enlargement: could a combination of doxazosin and finasteride change clinical practice?
    Fitzpatrick JM, Kirby RS.
    BJU Int; 2004 May 18; 93(7):914-5. PubMed ID: 15142134
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D, Soebadi DM, Sugandi S, Birowo P, Djati W, Wahyudi I.
    Int J Urol; 2006 Nov 18; 13(11):1405-9. PubMed ID: 17083392
    [Abstract] [Full Text] [Related]

  • 10. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA, McVary KT.
    Int J Impot Res; 2008 Dec 18; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA, McConnell JD, Roehrborn CG, Meehan AG, Lee MW, Noble WR, Kusek JW, Nyberg LM, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.
    J Urol; 2006 Jan 18; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [Abstract] [Full Text] [Related]

  • 12. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ, Miner M.
    Clin Ther; 2007 Jan 18; 29(1):17-25. PubMed ID: 17379044
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R, Thalmann G, Reich O, Steif CG.
    Aktuelle Urol; 2004 Sep 18; 35(5):339-42. PubMed ID: 15383991
    [No Abstract] [Full Text] [Related]

  • 14. [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].
    MMW Fortschr Med; 2003 Nov 20; 145(47):62. PubMed ID: 14725041
    [No Abstract] [Full Text] [Related]

  • 15. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H, Hux M, Brisson M, Bernard L, Nickel JC.
    Can J Urol; 2004 Aug 20; 11(4):2327-40. PubMed ID: 15380054
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
    Trinkler FB.
    Praxis (Bern 1994); 1997 Aug 20; 86(34):1305-6. PubMed ID: 9381019
    [No Abstract] [Full Text] [Related]

  • 17. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B, Gratzke C, Weidlich P, Seitz M, Reich O, Stief CG.
    MMW Fortschr Med; 2007 Aug 16; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [Abstract] [Full Text] [Related]

  • 18. [5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].
    MMW Fortschr Med; 2003 Jul 10; 145(27-28):58-9. PubMed ID: 14587193
    [No Abstract] [Full Text] [Related]

  • 19. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct 31; 144(44):56. PubMed ID: 12494605
    [No Abstract] [Full Text] [Related]

  • 20. [The doxazosin treatment of the changes in the bladder filling phase in benign prostatic hyperplasia].
    Salinas Casado J, Esteban Fuertes M, Virseda Chamorro M, Ramírez Fernández JC, Salomón Moh'd S, Luengo Alpuente S, Resel Estévez L.
    Arch Esp Urol; 1997 Oct 31; 50(8):840-5. PubMed ID: 9463281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.